[18F]MK-3328

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Alzheimer's Disease

Phase 1

Safety, Radiation Dosimetry, Biokinetics, and Effectiveness of [18F]MK3328 (MK-3328-001)

CompletedNCT00954538

Merck Sharp & Dohme LLCAlzheimer's Disease

Start: 2009-08-31End: 2011-05-31Updated: 2015-11-03

[18F]MK-3328 as a Possible Novel Positron Emission Tomography (PET) Tracer for the Detection of Brain Amyloid Plaques (MK-3328-002)

TerminatedNCT01385033

Merck Sharp & Dohme LLCAlzheimer's Disease

Start: 2011-08-19End: 2012-05-15Updated: 2018-11-08